Pediatric Cancer & Blood Disorder Clinical Trials & Studies
Access to More Clinical Trials and Innovative Therapies
Innovative clinical trials and drug development are creating new treatment paradigms and changing adolescent and young adult cancer treatment. Because of the strength of our research enterprise, our patients have access to new and promising treatment options. For example, we are one of only a few medical centers globally to offer groundbreaking RUBY CRISPR therapy to young adults with Sickle Cell Disease. This highly advanced therapy modifies a patient’s own cells to reduce harmful sickle cell-related pain crises.
Our collaborative and multi-disciplinary approach makes clinical trials more accessible to pediatric patients. In addition, by working closely with the UH Seidman Cancer Center for adults, we can offer adolescent, and young adult patients access to the same clinical trials typically only available for older patients.